Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13136
Country/Region: Uganda
Year: 2015
Main Partner: Makerere University
Main Partner Program: Infectious Disease Institute
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $3,244,252 Additional Pipeline Funding: $1,025,247

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $929,475
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $148,826
Care: Pediatric Care and Support (PDCS) $282,298
Laboratory Infrastructure (HLAB) $65,307
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $113,614
Testing: HIV Testing and Counseling (HVCT) $596,655
Sexual Prevention: Other Sexual Prevention (HVOP) $96,302
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $154,727
Treatment: Adult Treatment (HTXS) $829,268
Treatment: Pediatric Treatment (PDTX) $27,780
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 11,442
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,162
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 22,338
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 1,380
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 36,322
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 36,322
CARE_NEW Aggregated Age/sex: <15 Female 2016 364
CARE_NEW Aggregated Age/sex: <15 Male 2016 322
CARE_NEW Aggregated Age/sex: 15+ Female 2016 6,283
CARE_NEW Aggregated Age/sex: 15+ Male 2016 3,417
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 10,386
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 10,386
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 10,386
FN_THER Aggregated Age: <18 2016 336
FN_THER Aggregated Age: 18+ 2016 536
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 872
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 10,897
FN_THER Sum of Aggregated Age disaggregates 2016 872
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 14,281
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 10,774
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 109,192
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 78,668
HTS_TST By Test Result: Negative 2016 204,682
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 212,915
HTS_TST Sum of Aggregated Age/Sex <15 2016 25,055
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 187,860
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 212,915
HTS_TST Sum of Test Result disaggregates 2016 212,915
HTS_TST_POS By Test Result: Positive 2016 8,233
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 3,297
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 3,297
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 2,476
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 821
PMTCT_ARV Sum of New and Current disaggregates 2016 3,297
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 266
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 2,638
PMTCT_EID Sum of Infant Age disaggregates 2016 2,638
PMTCT_STAT By: Known positives at entry 2016 2,476
PMTCT_STAT By: Number of new positives identified 2016 821
PMTCT_STAT Number of new ANC and L&D clients 2016 30,842
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 29,300
PMTCT_STAT Sum of Positives Status disaggregates 2016 3,297
PP_PREV Age/sex: 10-14 Female 2016 5,246
PP_PREV Age/sex: 10-14 Male 2016 3,988
PP_PREV Age/sex: 15-19 Female 2016 9,125
PP_PREV Age/sex: 15-19 Female 2016 236
PP_PREV Age/sex: 15-19 Male 2016 7,434
PP_PREV Age/sex: 15-19 Male 2016 268
PP_PREV Age/sex: 20-24 Female 2016 13,469
PP_PREV Age/sex: 20-24 Female 2016 407
PP_PREV Age/sex: 20-24 Male 2016 8,232
PP_PREV Age/sex: 20-24 Male 2016 345
PP_PREV Age/sex: 25-49 Female 2016 19,494
PP_PREV Age/sex: 25-49 Female 2016 804
PP_PREV Age/sex: 25-49 Male 2016 14,258
PP_PREV Age/sex: 25-49 Male 2016 851
PP_PREV Age/sex: 50+ Female 2016 1,304
PP_PREV Age/sex: 50+ Female 2016 119
PP_PREV Age/sex: 50+ Male 2016 1,205
PP_PREV Age/sex: 50+ Male 2016 202
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 83,755
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 3,232
PP_PREV Sum of Age/Sex disaggregates 2016 83,755
PP_PREV Sum of Age/Sex disaggregates 2016 3,232
PP_PREV Total number of people in the target population 2016 209,389
TB_ART Aggregated Age: <15 2016 12
TB_ART Aggregated Age: 15+ 2016 158
TB_ART Female 2016 110
TB_ART Male 2016 60
TB_ART Sum of Aggregated Age disaggregates 2016 170
TB_ART Sum of Sex disaggregates 2016 170
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 213
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 170
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 2,543
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 33,779
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 36,322
TB_SCREEN Sex: Female 2016 23,718
TB_SCREEN Sex: Male 2016 12,604
TB_SCREEN Sum of Aggregated Age disaggregates 2016 36,322
TB_SCREEN Sum of Sex disaggregates 2016 36,322
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 36,322
TX_CURR Aggregated Age/Sex: 15+ Female 2016 9,960
TX_CURR Aggregated Age/Sex: 15+ Male 2016 21,641
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 34,112
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 31,601
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 31,601
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 2,676
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 5,654
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 8,690
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 8,330
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 4,285
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 5,041
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2016 11
VMMC_CIRC By circumcision technique: Device-based VMMC 2016 150
VMMC_CIRC By circumcision technique: Surgical VMMC 2016 3,159
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2016 3,159
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2016 3,249
VMMC_CIRC By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2016 60
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 3,309
Cross Cutting Budget Categories and Known Amounts Total: $1,400,000
Gender: Gender Based Violence (GBV) $400,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Gender: Gender Equality $200,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Key Populations: Sex Workers $400,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Key Populations: MSM and TG $400,000
Training of health workers and community outreach workers